Knowledge Center

Patent / Aug 02, 2018

Minocycline base polymorphic forms and its preparation method

Authors:
  • Zita Mendes
  • Constanca Cacela
  • Gloria Ten Figas
  • Ana Casares
Source:
PT 110699 - 20180802

The present invention relates to a minocycline in V cryst. form with a X diffractogram ratio having peaks at 2.9; 5.34; 7.9; 12.94; 15.06; 16.74; 18.22; 19.78; 21.06; 22.26; 23.02; 25.42 卤> 0.2掳2胃.听 A method preps. the new polymorphic forms IV and V by dissolving and鈥/or suspending minocycline on the basis of an org. solvent followed by crystn., and their use in pharmaceutical compn.

听

听

听

Also in the Knowledge Center

Related Content

Dry Powder Inhalation formulation development

四色AV has considerable inhalation experience that allows us to implement strategies including conventional carrier based, neat (drug-alone) or composite particle formulations.

Page
Read more

Corticosteroids

Corticosteroids are produced in two dedicated buildings on the Loures site, which are equipped with vessels ranging from 50L up to 4000L.

Page
Read more

顿颈蝉辫别谤蝉辞尘别庐

Make your drug soluble with 顿颈蝉辫别谤蝉辞尘别庐 technology. 顿颈蝉辫别谤蝉辞尘别庐 is a solubility enhancement technology that relies on an innovative and naturally occurring excipient to develop amorphous solid dispersions with high drug loading and high bioavailability.

Page
Read more